Amneal Pharmaceuticals, Inc. - Class A Common Stock (NY:AMRX)
Press Releases about Amneal Pharmaceuticals, Inc. - Class A Common Stock


Via Business Wire

Amneal Reports First Quarter 2024 Financial Results
May 03, 2024
Via Business Wire



Amneal to Report First Quarter 2024 Results on May 3, 2024
April 10, 2024
Via Business Wire

Amneal to Ring the Nasdaq Closing Bell on April 2, 2024
March 28, 2024
Via Business Wire





Amneal to Participate at Upcoming Investor Conference
February 13, 2024
Via Business Wire


Via Business Wire


Via Business Wire

Amneal Announces Move to Nasdaq
December 15, 2023
Via Business Wire

Via Business Wire


Amneal Reports Third Quarter 2023 Financial Results
November 07, 2023
Via Business Wire

Amneal to Participate at Upcoming Investor Conferences
November 03, 2023
Via Business Wire



Amneal to Report Third Quarter 2023 Results on November 7, 2023
October 05, 2023
Via Business Wire

Amneal Receives U.S. FDA Approval for Calcium Gluconate Injection
September 06, 2023
Via Business Wire

Amneal Receives First Product Approval in China
September 06, 2023
Via Business Wire

Amneal Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate
September 06, 2023
Via Business Wire


Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.